TRAVERE THERAPEUTICS

Lobbying client · California · filed 2025 to 2026

Biopharmaceuticals

$1,070,000 Reported spend

6 Filings counted

1 Firms hired

10 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (200929), not by name.

Firms hired 1

TRAVERE THERAPEUTICS $1,070,000 6 filings

Bills named in these filings 10

S 1040
A bill to amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Vete…

6 filings
HR 1262
Mikaela Naylon Give Kids a Chance Act

6 filings
HR 1414
Cameron’s Law

6 filings
HR 1518
New Era of Preventing End-Stage Kidney Disease Act

6 filings
HR 946
ORPHAN Cures Act

6 filings
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

5 filings
S 1862
ORPHAN Cures Act

5 filings
HR 4709
Newborn Screening Saves Lives Reauthorization Act of 2025

4 filings
HR 9102
BINSA Act

1 filing
S 2658
Medication Affordability and Patent Integrity Act

1 filing

Reported by year 2 years

2026 $340,000 2 filings
2025 $730,000 4 filings

Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Centers For Medicare and Medicaid Services (CMS) 6
Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 6 total

Q2

TRAVERE THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $140,000 expenses · posted Jul 20, 2026

View → Q1

TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $200,000 expenses · posted Apr 20, 2026

View → Q4

TRAVERE THERAPEUTICS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $260,000 expenses · posted Jan 19, 2026

View → Q3

TRAVERE THERAPEUTICS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $110,000 expenses · posted Oct 16, 2025

View → Q2

TRAVERE THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $200,000 expenses · posted Jul 17, 2025

View → Q1

TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $160,000 expenses · posted Apr 16, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.